Publications by authors named "Meng-Ling Ruan"
This study aims to investigate the effect of different levels of zinc oxide quantum dots (ZnO-QDs) on the growth performance and gut health in broilers. A total of 1125 1-day-old Ross 308 broilers were randomly divided into five groups with 15 replicates of 15 chicks each. The broilers were fed basal diets supplemented with 0, 40, 80, 120, or 160 mg Zn/kg as ZnO-QDs for 6 weeks.
View Article and Find Full Text PDFThis study was to evaluate the efficacy of an integrated mycotoxin-mitigating agent in reducing the adverse effects of co-occurring dietary aflatoxin B deoxynivalenol and ochratoxin A on broiler breeder hens. 360 30-week-old Hubbard Efficiency Plus broiler breeder hens were allocated into four groups and received a basal diet (BD; Control), BD added 0.15 mg/kg aflatoxin B+1.
View Article and Find Full Text PDFThis study was to evaluate the efficacy of TOXO-XL (XL), an integrated mycotoxin-mitigating agent, on aflatoxin B (AFB)-induced damage in Leghorn male hepatoma (LMH), porcine jejunum epithelial cell line (IPEC-J2) and porcine alveolar macrophages (3D4/21) cells, and to explore its potential mechanisms. The results showed that 30% inhibition concentration (IC) of AFB in LMH, IPEC-J2 and 3D4/21 cells was 0.5, 15.
View Article and Find Full Text PDFArticle Synopsis
- Fecal microbiota transplantation (FMT) shows promise as a treatment for various intestinal disorders in children, but concerns about long-term safety and effectiveness remain, with only a few studies focusing on children.
- In a study of 74 patients who received 508 FMT treatments, short-term adverse events were noted in 35.1% of participants, mostly occurring within 2 days and were typically self-limiting, with ulcerative colitis linked to higher event rates.
- While the initial clinical remission rate post-FMT was high at 72.9%, it declined over time, and follow-ups revealed no significant long-term health issues, though some children experienced minor conditions like rhinitis and constipation.
Article Synopsis
- The study explores the effects of fecal microbiota transplantation (FMT) on infants suffering from allergic colitis (AC), focusing on symptom relief and changes in gut microbiota.
- After FMT, 17 out of 19 infants experienced symptom relief within two days, with no relapses observed over 15 months, indicating a strong clinical success rate.
- Analysis of stool samples showed an increase in gut microbiota diversity and specific shifts in bacterial composition, suggesting that FMT not only alleviates AC symptoms but also enhances gut health.